How has COVID-19 pandemic affected numbers of newly identified cancer patients?
Read more here.
Addressing a public health crisis: applications for COVID-19 antibody testing
Education for Testing Fertility Patients during COVID-19
Watch our on-demand webinar here
Key findings from the Quest Diagnostics Health Trends report, Drug Misuse in America 2019
Listen to the new podcast episode here
How has the COVID-19 pandemic affected diabetes monitoring?
Learn more here
Assessment of plasma β-Amyloid 1-42/1-40 ratio may help identify patients with Alzheimer’s Disease
Click here to learn more
Non-invasive prenatal cell-free DNA screening
A recent study indicates high specificity and sensitiivity not only for women at high-risk, but also for women at average risk.
• Identify key coagulation markers that are associated with increased mortality in COVID-19 infected patients • Distinguish COVID-19 hypercoagulability from other hypercoagulable states • Understand... Read more ▸
Program objectives Participants will learn the following: • Taking a good sexual history • STI screening for specific patient populations • Implementation and operationalization of... Read more ▸
Presented by: William A. Meyer III, PhD, D (ABMM), MLS (ASCP) Moderated by: Hema Kapoor, MD, D (ABMM), SM Program objectives At the conclusion of... Read more ▸
Expert InsightsView All Expert Insights ▸
PublicationsView All Publications ▸
Eur J Hum Genet. 2020 Nov;28(11):1497-1508. doi: 10.1038/s41431-020-0668-y. Epub 2020 Jun 23.
Ann Neurol. 2020 Oct 21. doi: 10.1002/ana.25941. Online ahead of print.
Impact of a Digital Diabetes Prevention Program on Risk factors for Chronic Disease in a Workforce Cohort
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Sweet CMC
J Occup Environ Med. 2020 Oct 13. doi: 10.1097/JOM.0000000000002044. Online ahead of print.